- Exchange: EN Brussels
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
TiGenix NV+ Add to Watchlist
TIG:BB0.9000 EUR 0.0100 1.10%
As of 11:35:00 ET on 03/07/2014.
Company Profile for TiGenix NV (TIG)
TiGenix N.V. is a biomedical company focused on cell therapy. The Company researches and develops treatments for autoimmune and inflammatory diseases.
Key Executives for TiGenix NV (TIG)
|Eduardo BravoCEO/Joint Managing Director||Claudia D AugustaCFO/Secy/Compliance Officer|
|Gil BeyenChief Business Ofcr/Co-Founder||Wilfried DalemansChief Technology Officer|
|Hans HerklotsDir:Investor & Media Relations|